Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization - Fig 2

<p><b>Cumulative probability of event-free survival for (A) myocardial infarction, (B) cerebrovascular accident, (C) cardiovascular death, and (D) primary composite endpoint.</b> The primary outcome was a composite of myocardial infarction (MI), cerebrovascular accident (CVA), or cardiovascular death. A higher recurrent MI rate in the IABP group than the Nonuser group (7% versus 6.9%, p = 0.001). The rate of CVA was similar between the two groups (5% versus 6.3%, p = 0.654). A higher cardiovascular death rate in the IABP group than the Nonuser group (36.9% versus 24%, p<0.001). More composite primary outcome occurred in IABP group than Nonuser group (45.2% versus 34.1%, p<0.001).</p

Primary outcomes in the short-term and long-term follow-up periods.

<p>Primary outcomes in the short-term and long-term follow-up periods.</p

Baseline characteristics of the patients.

<p>Baseline characteristics of the patients.</p

Revascularization in the short-term and long-term follow-up periods.

<p>Revascularization in the short-term and long-term follow-up periods.</p

Flowchart of Inclusion.

<p>Individuals with AMI and severe cardiogenic shock undergoing coronary revascularization were included in our analysis after relevant exclusions (AMI = acute myocardial infarction, PCI = percutaneous coronary intervention, CABG = coronary artery bypass surgery, IABP = intraaortic balloon pump).</p

In-hospital events during the index AMI hospitalization.

<p>In-hospital events during the index AMI hospitalization.</p